5-methyl-4-oxo-4,5-dihydroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid(SALTDATA: FREE)
- $155 - $390
- Product name: 5-methyl-4-oxo-4,5-dihydroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid(SALTDATA: FREE)
- CAS: 1104927-34-5
- MF: C7H5N3O4
- MW: 195.13
- EINECS:
- MDL Number:MFCD12027392
- Synonyms:5-methyl-4-oxo-4,5-dihydroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid(SALTDATA: FREE);5-methyl-4-oxo-4,5-dihydroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid(SALTDATA;Isoxazolo[5,4-d]pyrimidine-3-carboxylic acid, 4,5-dihydro-5-methyl-4-oxo-
3 prices
Selected condition:
Brand
- AK Scientific
- Matrix Scientific
- TRC
Package
- 100mg
- 500mg
- ManufacturerAK Scientific
- Product number8727AC
- Product description5-Methyl-4-oxo-4,5-dihydroisoxazolo-[5,4-d]pyrimidine-3-carboxylicacid
- Packaging500mg
- Price$390
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number038542
- Product description5-Methyl-4-oxo-4,5-dihydroisoxazolo-[5,4-d]pyrimidine-3-carboxylic acid
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB496425
- Product description5-Methyl-4-oxo-4,5-dihydroisoxazolo[5,4-d]pyrimidine-3-carboxylicAcid
- Packaging100mg
- Price$155
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8727AC | 5-Methyl-4-oxo-4,5-dihydroisoxazolo-[5,4-d]pyrimidine-3-carboxylicacid | 500mg | $390 | 2021-12-16 | Buy |
Matrix Scientific | 038542 | 5-Methyl-4-oxo-4,5-dihydroisoxazolo-[5,4-d]pyrimidine-3-carboxylic acid | 500mg | $252 | 2021-12-16 | Buy |
TRC | B496425 | 5-Methyl-4-oxo-4,5-dihydroisoxazolo[5,4-d]pyrimidine-3-carboxylicAcid | 100mg | $155 | 2021-12-16 | Buy |
Properties
Boiling point :508.5±60.0 °C(Predicted)
Density :1.84±0.1 g/cm3(Predicted)
pka :2.63±0.20(Predicted)
Density :1.84±0.1 g/cm3(Predicted)
pka :2.63±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|